UTMD
Utah Medical Products, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$71.10
+0.55%Year over year
Reported trailing growth
- Revenue
- -7.0%
- EBITDA
- -17.0%
- EBIT
- -18.6%
- EPS
- -12.3%
- Free cash flow
- -18.4%
- Operating cash flow
- -16.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -9.7%
- EBITDA
- -15.0%
- EBIT
- -16.8%
- Net income
- -11.8%
- EPS
- -8.4%
- Free cash flow
- -11.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026